The Christ Hospital

A revolutionary artificial heart, Bivacor Total Heart Artificial, is in early FDA approval stages and has been implanted in a few patients worldwide. Mike Herrman, a 62-year-old with hypertrophic cardiomyopathy, received the device as a bridge to a heart transplant, feeling better than he had in decades. The device could significantly extend patient life compared to traditional heart transplants.

Shockwave Medical announces first clinical outcomes for Shockwave Javelin Peripheral Intravascular Lithotripsy (IVL) Catheter, showing 99% technical acute procedural success rate. The non-balloon-based lithotripsy platform is designed for patients with peripheral artery disease (PAD). Results support FDA clearance, and the device is expected to have a limited market release soon.